Global and United States Prostate Cancer Diagnostics Solution Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Prostate Cancer Diagnostics Solution Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Prostate Cancer Diagnostics Solution Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Prostate Cancer Diagnostics Solution Market Size for the Year 2017-2028
  • 1.2.2 Global Prostate Cancer Diagnostics Solution Market Size for the Year 2017-2028
• 1.3 Prostate Cancer Diagnostics Solution Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Prostate Cancer Diagnostics Solution in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Prostate Cancer Diagnostics Solution Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Prostate Cancer Diagnostics Solution Market Dynamics
  • 1.4.1 Prostate Cancer Diagnostics Solution Industry Trends
  • 1.4.2 Prostate Cancer Diagnostics Solution Market Drivers
  • 1.4.3 Prostate Cancer Diagnostics Solution Market Challenges
  • 1.4.4 Prostate Cancer Diagnostics Solution Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Prostate Cancer Diagnostics Solution by Type

• 2.1 Prostate Cancer Diagnostics Solution Market Segment by Type
  • 2.1.1 Tumor Biomarker Tests
  • 2.1.2 Imaging
  • 2.1.3 Biopsy
  • 2.1.4 Other
• 2.2 Global Prostate Cancer Diagnostics Solution Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Prostate Cancer Diagnostics Solution Market Size by Type (2017-2028)
• 2.4 United States Prostate Cancer Diagnostics Solution Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Prostate Cancer Diagnostics Solution Market Size by Type (2017-2028)

3 Prostate Cancer Diagnostics Solution by Application

• 3.1 Prostate Cancer Diagnostics Solution Market Segment by Application
  • 3.1.1 Age Below 55
  • 3.1.2 Age 55-75
  • 3.1.3 Age Above 75
• 3.2 Global Prostate Cancer Diagnostics Solution Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Prostate Cancer Diagnostics Solution Market Size by Application (2017-2028)
• 3.4 United States Prostate Cancer Diagnostics Solution Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Prostate Cancer Diagnostics Solution Market Size by Application (2017-2028)

4 Global Prostate Cancer Diagnostics Solution Competitor Landscape by Company

• 4.1 Global Prostate Cancer Diagnostics Solution Market Size by Company
  • 4.1.1 Top Global Prostate Cancer Diagnostics Solution Companies Ranked by Revenue (2021)
  • 4.1.2 Global Prostate Cancer Diagnostics Solution Revenue by Player (2017-2022)
• 4.2 Global Prostate Cancer Diagnostics Solution Concentration Ratio (CR)
  • 4.2.1 Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate Cancer Diagnostics Solution in 2021
  • 4.2.3 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Prostate Cancer Diagnostics Solution Headquarters, Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Prostate Cancer Diagnostics Solution Headquarters and Area Served
  • 4.3.2 Global Prostate Cancer Diagnostics Solution Companies Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Prostate Cancer Diagnostics Solution Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Prostate Cancer Diagnostics Solution Market Size by Company
  • 4.5.1 Top Prostate Cancer Diagnostics Solution Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Prostate Cancer Diagnostics Solution Revenue by Players (2020, 2021 & 2022)

5 Global Prostate Cancer Diagnostics Solution Market Size by Region

• 5.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Prostate Cancer Diagnostics Solution Market Size by Region (2017-2028)
  • 5.2.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2017-2022
  • 5.2.2 Global Prostate Cancer Diagnostics Solution Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Prostate Cancer Diagnostics Solution Market Size YoY Growth 2017-2028
  • 6.1.2 North America Prostate Cancer Diagnostics Solution Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Prostate Cancer Diagnostics Solution Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Prostate Cancer Diagnostics Solution Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Prostate Cancer Diagnostics Solution Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Prostate Cancer Diagnostics Solution Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
  • 6.4.6 Colombia
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Prostate Cancer Diagnostics Solution Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Prostate Cancer Diagnostics Solution Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 OPKO
  • 7.1.1 OPKO Company Details
  • 7.1.2 OPKO Business Overview
  • 7.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction
  • 7.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.1.5 OPKO Recent Development
• 7.2 Genomic Health
  • 7.2.1 Genomic Health Company Details
  • 7.2.2 Genomic Health Business Overview
  • 7.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction
  • 7.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.2.5 Genomic Health Recent Development
• 7.3 Abbott
  • 7.3.1 Abbott Company Details
  • 7.3.2 Abbott Business Overview
  • 7.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction
  • 7.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.3.5 Abbott Recent Development
• 7.4 Beckman Coulter
  • 7.4.1 Beckman Coulter Company Details
  • 7.4.2 Beckman Coulter Business Overview
  • 7.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction
  • 7.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.4.5 Beckman Coulter Recent Development
• 7.5 Siemens Healthcare
  • 7.5.1 Siemens Healthcare Company Details
  • 7.5.2 Siemens Healthcare Business Overview
  • 7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction
  • 7.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.5.5 Siemens Healthcare Recent Development
• 7.6 bioMeriux
  • 7.6.1 bioMeriux Company Details
  • 7.6.2 bioMeriux Business Overview
  • 7.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction
  • 7.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.6.5 bioMeriux Recent Development
• 7.7 Roche
  • 7.7.1 Roche Company Details
  • 7.7.2 Roche Business Overview
  • 7.7.3 Roche Prostate Cancer Diagnostics Solution Introduction
  • 7.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.7.5 Roche Recent Development
• 7.8 MDx Health
  • 7.8.1 MDx Health Company Details
  • 7.8.2 MDx Health Business Overview
  • 7.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction
  • 7.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.8.5 MDx Health Recent Development
• 7.9 DiaSorin
  • 7.9.1 DiaSorin Company Details
  • 7.9.2 DiaSorin Business Overview
  • 7.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction
  • 7.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.9.5 DiaSorin Recent Development
• 7.10 Myriad Genetics
  • 7.10.1 Myriad Genetics Company Details
  • 7.10.2 Myriad Genetics Business Overview
  • 7.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction
  • 7.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.10.5 Myriad Genetics Recent Development
• 7.11 Ambry Genetics
  • 7.11.1 Ambry Genetics Company Details
  • 7.11.2 Ambry Genetics Business Overview
  • 7.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction
  • 7.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
  • 7.11.5 Ambry Genetics Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details